Close
The EVIE Research Group
The EVIE group bring together multi-disciplinary research expertise across different institutions at UCL with the objective of synthesising high-quality evidence to inform clinical practice on women’s health matters.
Our group has advanced expertise in conducting systematic reviews, advanced meta-analyses (effectiveness, diagnostic accuracy, network, and Individual patient-level data), health economic analyses, development of evidence implementation tools, and clinical practice guidelines.
The EVIE group is particularly focused on effective patient and public involvement in the process of evidence synthesis to directly address the real health needs of women and their families.
Group Leads
Dr. Bassel H. Al Wattar
Bassel is a consultant Obstetrician and Gynaecologist and a subspecialist in Reproductive Medicine. His research portfolio is focused on evaluating effective interventions for couples with subfertility with a special interest in women with ovulatory and endocrine disorders such as polycystic ovary syndrome.
He is passionate about developing advanced methodology to assess the integrity and trustworthiness of studies included in systematic reviews and on developing tools for effective patient and public engagement in the process of evidence synthesis.
ORCID: 0000-0001-8287-927
IRIS: BWATT10
Ewelina is a research fellow at the Meta-Analysis Group, MRC CTU with an extensive experience in conducting evidence synthesis projects. Her expertise covers evaluation of treatments and medical tests in advanced evidence synthesis such as Individual Participant Data meta-analysis and network meta-analysis. She has a strong interest in methodological aspects of conducting evidence synthesis and research integrity in the context of evidence synthesis. She is passionate about delivering relevant and robust evidence synthesis in a timely manner.
ORCID: 0000-0003-3455-0644
IRIS: EAROG48
Methodology
CCTU is involved in early-phase dose finding clinical trials methodology.
Examples of publications include:
- Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.
- Controlled backfill in oncology dose-finding trials.
- Sample size calculation in randomised phase II selection trials using a margin of practical equivalence.